Areas of Focus
- 干细胞多能性以及重编程机制
- 细胞命运决定机制
Work Experience
- 2018-01~现在 - 中国科学院广州生物医药与健康研究院 - 副研究员
- 2014-08~2017-01 - 中国科学院广州生物医药与健康研究院 - 助理研究员
Academic Background & Achievements
- 2009-09--2014-06 理学博士: 中国科学院广州生物医药与健康研究院
- 2005-09--2009-06 理学学士: 南京农业大学
Publications
- AP-1 activity is a major barrier of human somatic cell reprogramming, 第8作者, 2021
- Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming, 通讯作者, 2020
- BMP4 resets mouse epiblast stem cells to naive pluripotency through ZBTB7A/B-mediated chromatin remodelling, 第18作者, 2020
- JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency, 第22作者, 2020
- SETDB1-Mediated Cell Fate Transition between 2C-Like and Pluripotent States, 第9作者, 2020
- Resolving Cell Fate Decisions during Somatic Cell Reprogramming by Single-Cell RNA-Seq, 第1作者, 2019
- Chromatin Accessibility Dynamics during iPSC Reprogramming, 第8作者, 2017
- Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage, 第14作者, 2017
- Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function, 第15作者, 2017
- The oncogene c-Jun impedes somatic cell reprogramming, 第18作者, 2015
- Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity, 第2作者, 2014
- Vitamin C modulates TET1 function during somatic cell reprogramming, 未提及, 2013
- H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs, 第11作者, 2013
- Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics, 第10作者, 2011
Awards
- 干细胞多能性与重编程机理 (2017): 部委级
